Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Invico Capital is a Canadian asset management firm specializing in alternative investment funds. It is not a life sciences or healthcare company. The firm manages over $3 billion CAD in private capital with offerings that include private debt financing, real estate lending solutions, energy sector investments, and restructuring distressed assets. Founded in Calgary in 2005 by Allison Taylor and Jason Brooks, it remains owner-managed with a focus on diversity. The company also operates under the name Pennant Capital Partners for certain wholesale activities. There are no indications of involvement with drug development or healthcare technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Invico Capital.